PharmaLex Denmark A/S: Financial statements 2017
CVR: 18652439
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
PharmaLex Denmark A/S (CVR 18652439) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 14,539,514 and a net result of DKK -1,627,342 compared with DKK 5,319,161 the year before. That is a decrease of 35% compared with the year before. Equity in the 2017 report amounted to DKK 1,248,069. The solvency ratio was 21.9%. The company had 21 employees in the financial year.
- Gross Profit
- DKK 14,539,514
- Profit/Loss
- DKK -1,627,342
- Equity
- DKK 1,248,069
- Total Assets
- DKK 5,688,291
- Employees
- 21
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 14.5 mio. | -1.6 mio. | 1.2 mio. | 21 |
| 2016 | - | 22.4 mio. | 5.3 mio. | 6.6 mio. | 30 |
| 2015 | - | 17.6 mio. | 321 t. | 4.9 mio. | - |
| 2014 | - | 15.4 mio. | 2.2 mio. | 6.8 mio. | - |
| 2013 | - | 12.7 mio. | 2.5 mio. | 6.9 mio. | - |
Official annual report
Keep an eye on PharmaLex Denmark A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
On November 6, 2017, the company changed its name from JACOBSEN PHARMA CONSULTANCY A/S to PharmaLex Denmark A/S.
As of November 6, 2017, Pharmalex Nordic ApS is registered as an owner of PharmaLex Denmark A/S with an ownership share of 100%.
PharmaLex Denmark A/S has published its annual report for 2016. Gross profit came to DKK 22,356,214, and the net result was DKK 5,319,161.
As of January 1, 2017, Anette Langgaard Jacobsen has joined the board of directors of PharmaLex Denmark A/S.
As of January 1, 2017, Solveig Blomvik has joined the board of directors of PharmaLex Denmark A/S.
As of January 1, 2017, Torben Thers Nørgaard has joined the board of directors of PharmaLex Denmark A/S.
As of January 1, 2017, Raphael Troost has left the board of directors of PharmaLex Denmark A/S.
As of January 1, 2017, Caren Ingrid Martini has left the board of directors of PharmaLex Denmark A/S.
As of January 1, 2017, Torben Thers Nørgaard is registered as adm. dir. of PharmaLex Denmark A/S.
As of January 1, 2017, Anette Langgaard Jacobsen has stepped down as director of PharmaLex Denmark A/S.
About PharmaLex Denmark A/S
PharmaLex Denmark A/S is a Danish company of the type Aktieselskab based in Kongens Lyngby, founded in 1995. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company was previously named JACOBSEN PHARMA CONSULTANCY A/S and SLP NR. 11.026 A/S. The management consists of Åsa Pihlblad. The board consists of Christopher Gauglitz (chair), Carlos Antonio Santaflorentina Juanino and Åsa Pihlblad. The company is owned by Pharmalex Nordic ApS. The company has 15 employees (2026). In 2025, the company reported a gross profit of DKK 17,235,093 and a net result of DKK -1,712,095 compared with DKK 1,745,746 the year before. Equity in the 2025 report amounted to DKK 2,761,242.